A Wider Range Rarely Earns More Revenue Abroad
Most brands treat revenue in a new market as a sum: more SKUs, more shelf presence, more sales. In practice, revenue is a product of three things: how many outlets list the product, how fast it sells in each, and the price it holds. The distributor and the retailer decide the first two, and they decide on early evidence.
Each added SKU therefore competes with the others for the same scarce resources. These are distributor sales attention, retailer listing slots, sampling budget and the brand's own working capital. Two SKUs that serve the same purchase occasion, such as adjacent sizes or similar flavours, usually split one pool of demand. Neither reaches the velocity a retailer needs to keep its listing, so the range grows while revenue per SKU falls.
Early velocity also compounds. A product that reorders quickly earns distributor confidence, better placement and the right to extend the range. A product that stalls triggers markdowns and delistings, and those damage the products that were selling well.
The commercial question is not "how much revenue can the full range generate?" It is "which combination of SKUs reaches reorder velocity first, and what is each additional SKU worth after the cannibalisation it causes?" The revenue-maximising range is usually narrower than the commercially comfortable one. It is staged, so that early sell-through funds and justifies each extension.
Executives should therefore test every proposed SKU for its incremental revenue, not its standalone appeal. If a product mostly displaces another in the range, it adds cost and complexity but little revenue.
Commercial impact: Revenue per listed SKU, not total listed SKUs, determines whether a distributor keeps investing in the brand.
Business risk: Overlapping SKUs dilute velocity across the range and put listings at risk when retailers review performance.
Decision quality: Ask what each SKU adds beyond what the Lead SKUs already capture, rather than whether it sells well.
Execution: Plan range extensions as a sequence triggered by reorder performance, so expansion is earned by evidence.
More Winning Products Don’t Always Mean a Winning Portfolio.
See the complete Portfolio Selection Framework to see how a ranked shortlist links market evidence to revenue-generating launch decisions.
Explore Our Portfolio Selection Framework